SYN1: A Potential Drug Target for Neurodegenerative Diseases (G6853)

Target Name: SYN1

NCBI ID: G6853

SYN1

SYN1: A Potential Drug Target for Neurodegenerative Diseases

SYN1 (X-linked 50) is a protein that is expressed in the brain and is associated with a number of neurodegenerative diseases, including Alzheimer's disease. The protein is located in the X chromosome, which means that it is only expressed in males.

SYN1 has been identified as a potential drug target for a number of reasons. One of the main reasons is that it is expressed in the brain and is involved in the development and progression of neurodegenerative diseases. This means that targeting the protein could potentially lead to new treatments for these conditions.

Another reason why SYN1 is a promising drug target is that it is involved in a number of different signaling pathways. For example, it is involved in the TGF-β pathway, which is a key signaling pathway that is involved in the development and maintenance of tissues in the brain.

In addition, SYN1 is also involved in the Wnt pathway, which is a signaling pathway that is involved in the development and maintenance of tissues in the body. This means that targeting the protein could potentially lead to new treatments for a number of different conditions.

Another potential reason why SYN1 is a promising drug target is that it is expressed in a number of different tissues and organs, including the brain, heart, and kidneys. This means that targeting the protein could potentially have a broader impact on a number of different conditions.

In addition, SYN1 is also involved in a number of different signaling pathways that are involved in the development and progression of neurodegenerative diseases. For example, it is involved in the 尾-amyloid pathway, which is a key pathway that is involved in the production of 尾-amyloid, a protein that is thought to contribute to the development of Alzheimer's disease.

Finally, SYN1 is also involved in the JAK/STAT signaling pathway, which is involved in the production of STAT3, a protein that is thought to contribute to the development of a number of different neurodegenerative diseases.

In conclusion, SYN1 is a protein that is associated with a number of neurodegenerative diseases and has been identified as a potential drug target. Its expression in the brain and involvement in a number of different signaling pathways make it an attractive target for research and development of new treatments. Further studies are needed to fully understand the role of SYN1 in the development and progression of neurodegenerative diseases and to determine its potential as a drug.

Protein Name: Synapsin I

Functions: Neuronal phosphoprotein that coats synaptic vesicles, and binds to the cytoskeleton. Acts as a regulator of synaptic vesicles trafficking, involved in the control of neurotransmitter release at the pre-synaptic terminal (PubMed:21441247, PubMed:23406870). Also involved in the regulation of axon outgrowth and synaptogenesis (By similarity). The complex formed with NOS1 and CAPON proteins is necessary for specific nitric-oxid functions at a presynaptic level (By similarity)

The "SYN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SYN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets